Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

1.110

-0.150 (-11.90%)

At close: Nov 5, 2026, 4:00 PM EST

1.144

+0.034 (3.05%)

After-hours: Nov 5, 2026, 7:30 PM EST

Anavex Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	118.33	102.58	132.19	151.02	149.16	152.11
Cash & Short-Term Investments	118.33	102.58	132.19	151.02	149.16	152.11
Cash Growth	16.96%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Other Receivables	1	0.81	2.45	2.71	3.19	9.14
Receivables	1	0.81	2.45	2.71	3.19	9.14
Prepaid Expenses	0.82	0.43	0.93	0.65	0.35	0.37
Total Current Assets	120.14	103.82	135.57	154.39	152.71	161.62
Total Assets	120.14	103.82	135.57	154.39	152.71	161.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	3.66	4.25	9.63	4.32	3.83	4.74
Accrued Expenses	4.04	3.37	4.28	5.99	5.95	5.61
Current Unearned Revenue	-	1.33	1.4	2.22	0.44	0.44
Total Current Liabilities	7.69	8.95	15.3	12.53	10.21	10.8
Total Liabilities	7.69	8.95	15.3	12.53	10.21	10.8

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	0.09	0.09	0.09	0.08	0.08	0.08
Additional Paid-In Capital	498	477.23	456.25	434.84	387.98	348.33
Retained Earnings	-385.64	-382.45	-336.07	-293.07	-245.56	-197.59
Shareholders' Equity	112.45	94.87	120.26	141.85	142.49	150.82
Total Liabilities & Equity	120.14	103.82	135.57	154.39	152.71	161.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Cash (Debt)	118.33	102.58	132.19	151.02	149.16	152.11
Net Cash Growth	16.96%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Net Cash Per Share	1.31	1.20	1.58	1.89	1.94	2.18
Filing Date Shares Outstanding	92.7	89.35	84.82	82.09	77.96	76.02
Total Common Shares Outstanding	92.7	86.67	84.8	82.07	77.94	75.92
Working Capital	112.45	94.87	120.26	141.85	142.49	150.82
Book Value Per Share	1.21	1.09	1.42	1.73	1.83	1.99
Tangible Book Value	112.45	94.87	120.26	141.85	142.49	150.82
Tangible Book Value Per Share	1.21	1.09	1.42	1.73	1.83	1.99

SEC Filings: 10-K · 10-Q